Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2001

01-02-2001

Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands

Focus on reproductive system

Authors: Emanuela Arvat, Laura Gianotti, Roberta Giordano, Fabio Broglio, Mauro Maccario, Fabio Lanfranco, Giampiero Muccioli, Mauro Papotti, Andrea Grazian, Ezio Ghigo, Romano Deghenghi

Published in: Endocrine | Issue 1/2001

Login to get access
Metadata
Title
Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands
Focus on reproductive system
Authors
Emanuela Arvat
Laura Gianotti
Roberta Giordano
Fabio Broglio
Mauro Maccario
Fabio Lanfranco
Giampiero Muccioli
Mauro Papotti
Andrea Grazian
Ezio Ghigo
Romano Deghenghi
Publication date
01-02-2001
Publisher
Humana Press
Published in
Endocrine / Issue 1/2001
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:14:1:035

Other articles of this Issue 1/2001

Endocrine 1/2001 Go to the issue

OriginalPaper

Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy

OriginalPaper

Do growth hormone-releasing peptides act as ghrelin secretagogues?

OriginalPaper

Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment

OriginalPaper

Presence of ghrelin in normal and adenomatous human pituitary

OriginalPaper

Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland

OriginalPaper

Recombinant human GHRH (1–44) NH2
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits